NCT00847314View on ClinicalTrials.gov

Efficacy and Tolerability of Testogel/Nebido in Combination With Exercise and Diet in Hypogonadal Male Patients

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Hypogonadism
Interventions
DRUG

Testosterone Undeconate (Nebido-R, BAY86-5037)

Male patients \> 35yrs in medical practices fulfilling all criteria for documentation.

Trial Locations (1)

Unknown

Many Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY